Dabigatran Etexilate Capsules Reference Listed Drug

* Please be kindly noted products are supplied for RLD supplies/ Reference listed drugs/ Comparator Drug Clinical trials. We do not sell to patients.

Name	Dabigatran Etexilate Capsules
Trade name	Pradaxa
Specifications	0.11g；0.15g
Dosage form	Capsules
Licensee	Boehringer Ingelheim International GmbH
Remarks	Original research import

This product is an antithrombotic drug used to prevent stroke and systemic embolism (SEE) in adult patients with non-valvular atrial fibrillation who have one or more of the following risk factors: previous stroke, transient ischemic attack or systemic Embolism; left ventricular ejection fraction<40%; symptomatic heart failure, New York Heart Association (NYHA) heart function classification ≥2; age ≥75 years old; age ≥65 years old, and accompanied by any of the following diseases : Diabetes, coronary heart disease or high blood pressure.

We are a global professional manufacturer and supplier of reference drug products, featuring high-quality services and competitive prices. You can get the most favorable reference drug prices here. If you need customized services, please contact us immediately.

Hot Tags: Dabigatran Etexilate Capsules Reference Listed Drug, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Argatroban Injection, AdapaleneGel, Adefovir Dipivoxil Tablets, Acarbose Tablets, Alfacalcidol Soft Capsules, Reference Listed Drugs

• Previous: Nifedipine Controlled-release Tablets Reference Listed Drug
• Next: Dapoxetine Hydrochloride Tablets Reference Listed Drug